These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 15649677

  • 21. Prescribing COX-2s for patients new to cyclo-oxygenase inhibition therapy.
    Cox ER, Motheral B, Frisse M, Behm A, Mager D.
    Am J Manag Care; 2003 Nov; 9(11):735-42. PubMed ID: 14626471
    [Abstract] [Full Text] [Related]

  • 22. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors.
    Battistella M, Mamdami MM, Juurlink DN, Rabeneck L, Laupacis A.
    Arch Intern Med; 2005 Jan 24; 165(2):189-92. PubMed ID: 15668365
    [Abstract] [Full Text] [Related]

  • 23. Persistency of use of COX-2-specific inhibitors and non-specific non-steroidal anti-inflammatory drugs (NSAIDs) in Quebec.
    Moride Y, Ducruet T, Rochon S, Lavoie F.
    Rheumatology (Oxford); 2003 Nov 24; 42 Suppl 3():iii17-22. PubMed ID: 14585914
    [Abstract] [Full Text] [Related]

  • 24. The hidden cost of nonselective nonsteroidal antiinflammatory drugs in older patients.
    Solomon DH, Glynn RJ, Bohn R, Levin R, Avorn J.
    J Rheumatol; 2003 Apr 24; 30(4):792-8. PubMed ID: 12672201
    [Abstract] [Full Text] [Related]

  • 25. Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines.
    Moride Y, Ducruet T, Boivin JF, Lavoie F, Rochon S.
    Can J Clin Pharmacol; 2005 Apr 24; 12(2):e201-11. PubMed ID: 15998959
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Nonselective and cyclooxygenase-2-selective NSAIDs and acute kidney injury.
    Winkelmayer WC, Waikar SS, Mogun H, Solomon DH.
    Am J Med; 2008 Dec 24; 121(12):1092-8. PubMed ID: 19028206
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Uptake of COX-2 selective inhibitors and influence on NSAID prescribing in Northern Ireland.
    Girvin B, Rafferty T, Stevenson MR, Johnston GD.
    Pharmacoepidemiol Drug Saf; 2004 Mar 24; 13(3):153-7. PubMed ID: 15072114
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY, Hwang SJ, Chen YC, Chen TJ, Lin MH, Chen LK.
    Clin Ther; 2009 Aug 24; 31(8):1859-70. PubMed ID: 19808145
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events.
    Thompson PW, Tee L, McBride J, Quincey D, Strat Liddiard G.
    Rheumatology (Oxford); 2005 Oct 24; 44(10):1308-10. PubMed ID: 15972345
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Factors associated with celecoxib and rofecoxib utilization.
    Rawson NS, Nourjah P, Grosser SC, Graham DJ.
    Ann Pharmacother; 2005 Apr 24; 39(4):597-602. PubMed ID: 15755796
    [Abstract] [Full Text] [Related]

  • 39. Analgesic prescribing for musculoskeletal complaints in the ambulatory care setting after the introduction and withdrawal of cyclooxygenase-2 inhibitors.
    Wilson RD.
    Arch Phys Med Rehabil; 2009 Jul 24; 90(7):1147-51. PubMed ID: 19577028
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.